Please ensure Javascript is enabled for purposes of website accessibility

Why Appian, CrowdStrike, and Zscaler Stocks Are Hurting Today

By Rich Smith - Feb 23, 2021 at 12:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analysts warn of a "risk cluster" in tech stocks.

What happened

Is this the market correction we've been waiting for? On Tuesday, the Nasdaq collapsed, falling nearly 4% in early trading before paring its losses to a decline of about 1.9% as of 10:30 a.m. EST, with tech investors worrying that their gains (200%, 300%, or more) over the past year might be imperiled by a recent rise in government bond rates.  

Tech shares are tumbling on no particular news, but plenty of worry about what this might mean, with Appian (APPN 3.55%), for example, falling 2.2%; CrowdStrike Holdings (CRWD 6.27%) down 5.8%; and Zscaler (ZS 7.20%) off 8%.

Each of these names had roughly quadrupled in share price over the past year of pandemic, giving investors a lot to lose if the market turns south.

Three arrows trending down over a background of a cityscape, map, and dollar signs

Image source: Getty Images.

So what

What could cause that to happen? Analysts warn of a "Tesla-Bitcoin-ARK Investment ... risk cluster" in which all sorts of companies and mutual funds are taking on all sorts of the same kinds of risk simultaneously -- such that if one thing goes wrong (Bitcoin falling 10% in a day, for example), the whole tangle threatens to fall apart. Bond rates are of particular concern, because the more money an investor can get from a so-called risk-free investment in bonds, the less likely that investor is going to be to want to invest in riskier stocks.  

Saxo Bank's equity strategy head, Peter Garnry, summed up the worries nicely earlier this month, opining that "a correction in equities for whatever reasons, [whether because of] higher interest rates or prolonged COVID-19 lockdowns, could set in motion sell-offs across either biotechnology stocks or Tesla shares and cause performance to deteriorate which could [spook investors into selling] and then the feedback loop has started."  

Now what

Now, the good news is that at least one of these reasons doesn't seem to be happening -- at least not immediately. In testimony before Congress this morning, Fed Chairman Jerome Powell said it will probably be "some time" before the Fed sees the economy as recovered enough that it can scale back the Fed's program of buying bonds. So long as it keeps buying, bond rates are likely to remain low, encouraging investors to continue taking greater risks in search of yield -- i.e., by buying stocks instead of bonds.

There are still other risks waiting in the wings, however, with Powell warning of "upward pressure on prices" for example, even as the economic recovery looks to have "slowed substantially," and senatorial questioners highlighting "warning signs that are certainly blinking yellow."  

Today's wave of selling may subside -- but the risks are still out there.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CrowdStrike Holdings, Inc. Stock Quote
CrowdStrike Holdings, Inc.
$155.84 (6.27%) $9.20
Appian Stock Quote
$46.05 (3.55%) $1.58
Zscaler Stock Quote
$142.13 (7.20%) $9.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.